BTC Health Limited (BTC.AX)
AUD 0.07
(9.23%)
AUD 0.07
(9.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 5.14 Million AUD | 75.03% |
| 2023 | 2.94 Million AUD | -77.4% |
| 2022 | 13.01 Million AUD | 0.26% |
| 2021 | 12.98 Million AUD | 13.33% |
| 2020 | 11.45 Million AUD | -2.24% |
| 2019 | 11.71 Million AUD | 253.48% |
| 2018 | 3.31 Million AUD | -28.96% |
| 2017 | 4.66 Million AUD | 72.41% |
| 2016 | 2.7 Million AUD | 156.85% |
| 2015 | 1.05 Million AUD | -17.97% |
| 2014 | 1.28 Million AUD | -59.45% |
| 2013 | 3.16 Million AUD | -35.71% |
| 2012 | 4.92 Million AUD | -58.05% |
| 2011 | 11.74 Million AUD | -27.2% |
| 2010 | 16.13 Million AUD | -31.18% |
| 2009 | 23.45 Million AUD | -16.66% |
| 2008 | 28.13 Million AUD | -25.87% |
| 2007 | 37.95 Million AUD | -20.81% |
| 2006 | 47.93 Million AUD | 12.95% |
| 2005 | 42.43 Million AUD | -12.14% |
| 2004 | 48.3 Million AUD | 22.69% |
| 2003 | 39.37 Million AUD | -0.02% |
| 2002 | 39.38 Million AUD | -1.79% |
| 2001 | 40.09 Million AUD | 0.12% |
| 2000 | 40.05 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 5.14 Million AUD | 0.0% |
| 2024 Q2 | 5.59 Million AUD | 0.0% |
| 2024 FY | 5.14 Million AUD | 75.03% |
| 2023 FY | 2.94 Million AUD | -77.4% |
| 2023 Q4 | 2.94 Million AUD | 0.0% |
| 2023 Q2 | 12.82 Million AUD | 0.0% |
| 2022 Q4 | 13.01 Million AUD | 0.0% |
| 2022 FY | 13.01 Million AUD | 0.26% |
| 2022 Q2 | 13.16 Million AUD | 0.0% |
| 2021 Q2 | 11.22 Million AUD | 0.0% |
| 2021 Q4 | 12.98 Million AUD | 0.0% |
| 2021 FY | 12.98 Million AUD | 13.33% |
| 2020 FY | 11.45 Million AUD | -2.24% |
| 2020 Q2 | 11.46 Million AUD | 0.0% |
| 2020 Q4 | 11.45 Million AUD | 0.0% |
| 2019 FY | 11.71 Million AUD | 253.48% |
| 2019 Q2 | 3 Million AUD | 0.0% |
| 2019 Q4 | 11.71 Million AUD | 0.0% |
| 2018 FY | 3.31 Million AUD | -28.96% |
| 2018 Q2 | 3.31 Million AUD | 0.0% |
| 2018 Q4 | 3.31 Million AUD | 0.0% |
| 2017 Q2 | 2.54 Million AUD | 0.0% |
| 2017 FY | 4.66 Million AUD | 72.41% |
| 2017 Q4 | 4.66 Million AUD | 0.0% |
| 2016 Q4 | 2.7 Million AUD | 0.0% |
| 2016 FY | 2.7 Million AUD | 156.85% |
| 2016 Q2 | 2.19 Million AUD | 0.0% |
| 2015 Q2 | 1.43 Million AUD | 0.0% |
| 2015 Q4 | 1.05 Million AUD | 0.0% |
| 2015 FY | 1.05 Million AUD | -17.97% |
| 2014 FY | 1.28 Million AUD | -59.45% |
| 2014 Q4 | 1.28 Million AUD | 0.0% |
| 2014 Q2 | 1.34 Million AUD | 0.0% |
| 2013 Q4 | 3.16 Million AUD | 0.0% |
| 2013 Q3 | 3.16 Million AUD | -2.86% |
| 2013 Q1 | 3.26 Million AUD | -33.82% |
| 2013 Q2 | 3.26 Million AUD | 0.0% |
| 2013 FY | 3.16 Million AUD | -35.71% |
| 2012 FY | 4.92 Million AUD | -58.05% |
| 2012 Q4 | 4.92 Million AUD | 0.0% |
| 2011 Q4 | 11.74 Million AUD | 0.0% |
| 2011 FY | 11.74 Million AUD | -27.2% |
| 2010 Q4 | 16.13 Million AUD | 0.0% |
| 2010 FY | 16.13 Million AUD | -31.18% |
| 2009 Q4 | 23.45 Million AUD | 0.0% |
| 2009 FY | 23.45 Million AUD | -16.66% |
| 2008 Q4 | 28.13 Million AUD | 0.0% |
| 2008 FY | 28.13 Million AUD | -25.87% |
| 2007 FY | 37.95 Million AUD | -20.81% |
| 2007 Q4 | 37.95 Million AUD | 0.0% |
| 2006 FY | 47.93 Million AUD | 12.95% |
| 2006 Q4 | 47.93 Million AUD | 0.0% |
| 2005 FY | 42.43 Million AUD | -12.14% |
| 2005 Q4 | 42.43 Million AUD | 0.0% |
| 2004 Q4 | 48.3 Million AUD | 0.0% |
| 2004 FY | 48.3 Million AUD | 22.69% |
| 2003 Q4 | 39.37 Million AUD | 0.0% |
| 2003 FY | 39.37 Million AUD | -0.02% |
| 2002 FY | 39.38 Million AUD | -1.79% |
| 2002 Q4 | 39.38 Million AUD | 0.0% |
| 2001 Q4 | 40.09 Million AUD | 0.0% |
| 2001 FY | 40.09 Million AUD | 0.12% |
| 2000 FY | 40.05 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 79.85% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -208.049% |
| Zelira Therapeutics Limited | 5.18 Million AUD | 0.668% |
| Biome Australia Limited | 8.27 Million AUD | 37.792% |
| Patrys Limited | 4.16 Million AUD | -23.722% |
| Orthocell Limited | 26.61 Million AUD | 80.655% |
| Imugene Limited | 151.39 Million AUD | 96.599% |
| Noxopharm Limited | 6.78 Million AUD | 24.101% |
| PYC Therapeutics Limited | 91.23 Million AUD | 94.357% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 66.289% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 74.752% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 52.655% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 38.619% |
| CSL Limited | 56.93 Billion AUD | 99.991% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 61.243% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -62.958% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 97.772% |
| Starpharma Holdings Limited | 36.81 Million AUD | 86.014% |
| Nanollose Limited | 241.95 Thousand AUD | -2028.037% |
| Memphasys Limited | 12.43 Million AUD | 58.578% |
| Invex Therapeutics Ltd | 6.12 Million AUD | 15.87% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | 5.281% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 65.316% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 95.422% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -100.775% |
| Race Oncology Limited | 20.22 Million AUD | 74.547% |
| Nyrada Inc. | 5.9 Million AUD | 12.839% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 98.707% |
| Dimerix Limited | 32.07 Million AUD | 83.949% |
| PharmAust Limited | 11.12 Million AUD | 53.718% |
| Immutep Limited | 147.44 Million AUD | 96.508% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 96.67% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 73.216% |
| Acrux Limited | 8.96 Million AUD | 42.555% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 97.924% |
| Biotron Limited | 493.47 Thousand AUD | -943.375% |
| Tissue Repair Ltd | 19.38 Million AUD | 73.445% |
| AdAlta Limited | 5.57 Million AUD | 7.612% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 92.852% |
| Hexima Limited | 2.26 Million AUD | -126.919% |
| AnteoTech Limited | 9.38 Million AUD | 45.116% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 81.202% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | 19.166% |
| Avecho Biotechnology Limited | 7.31 Million AUD | 29.654% |
| Actinogen Medical Limited | 21.31 Million AUD | 75.841% |
| Immuron Limited | 15.54 Million AUD | 66.889% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 68.562% |